Hepatic Parenchymal Changes following Transcatheter Embolization and Chemoembolization in a Rabbit Tumor Model

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wang, Yong ^a   Xiong, Bin ^a   Liang, Bin ^a   Zhao, Hui ^a   Li, Hui ^a   Qian, Jun ^a   Liang, Hui Min ^a   Feng, Gan Sheng ^a   Zheng, Chuan Sheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

10 HYDROXYCAMPTOTHECIN; ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; COLLAGEN; IODINATED POPPYSEED OIL; POLYVINYL ALCOHOL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CELL ACTIVATION; CELL PROLIFERATION; CHEMOEMBOLIZATION; CONTROLLED STUDY; FIBROGENESIS; HISTOLOGY; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER INJURY; LIVER PARENCHYMA; LIVER TUMOR; NONHUMAN; STELLATE CELL; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; CATHETERS; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE MODELS, ANIMAL; FIBROSIS; HEPATIC STELLATE CELLS; LIVER; LIVER FUNCTION TESTS; LIVER NEOPLASMS; NECROSIS; RABBITS;

EID: 84881528592     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070757     Document Type: Article

References (24)

1. Chan AO, Yuen MF, Hui CK, Tso WK, Lai CL, (2002) A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 94: 1747-1752.
2. Farinati F, De Maria N, Marafin C, Herszènyi L, Del Prato S, et al. (1996) Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig Dis Sci 41: 2332-2339.3.
3. Artinyan A, Nelson R, Soriano P, Chung V, Retseck J, et al. (2008) Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver. HPB (Oxford) 10: 396-404.
4. Khan KN, Nakata K, Kusumoto Y, Shima M, Ishii N, et al. (1991) Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma. Cancer Res 51: 5667-5671.
5. Caturelli E, Siena DA, Fusilli S, Villani MR, Schiavone G, et al. (2000) Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology 215: 123-128.
6. Chung J, Yu JS, Chung JJ, Kim JH, Kim KW, (2010) Haemodynamic events and localised parenchymal changes following transcatheter arterial chemoembolisation for hepatic malignancy: interpretation of imaging findings. Br J Radiol 83: 71-81.
7. Yu JS, Kim KW, Jeong MG, Lee DH, Park MS, et al. (2002) Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol 25: 270-274.
8. Yu JS, Kim KW, Park MS, Yoon SW, (2001) Bile duct injuries leading to portal vein obliteration after transcatheter arterial chemoembolization in the liver: CT findings and initial observations. Radiology 221: 429-436.
9. Itoh Y, Okanoue T, Ohnishi N, Nishioji K, Sakamoto S, et al. (1999) Hepatic damage induced by transcatheter arterial chemoembolization elevates serum concentrations of macrophage-colony stimulating factor. Liver 19: 97-103.
10. Kaneko A, Hayashi N, Tanaka Y, Ito T, Kasahara A, et al. (1992) Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy. Am J Gastroenterol 87: 1014-1017.
11. Reeves HL, Friedman SL, (2002) Activation of hepatic stellate cells-a key issue in liver fibrosis. Front Biosci 7: d808-826.
12. Li D, Friedman SL, (1999) Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol 14: 618-633.
13. Zhang H, Sun L, Wang W, Ma X, (2006) Quantitative analysis of fibrosis formation on the microcapsule surface with the use of picro-sirius red staining, polarized light microscopy, and digital image analysis. J Biomed Mater Res A 76: 120-125.
14. Wang Y, Zheng C, Liang B, Zhao H, Qian J, et al. (2011) Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model. J Vasc Interv Radiol 22: 1606-1612.
15. Beaussier M, Wendum D, Schiffer E, Dumont S, Rey C, et al. (2007) Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Lab Invest 87: 292-303.
16. Geerts A, (2001) History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 21: 311-35.
17. Kong J, Dou YC, Xu LF, Liang HM, Wu HP, et al. (2002) The New Method in Inspecting Liver Injure After Repeated Transcatheter Arterial Embolization for Treating Hepatocellular Carcinoma: The Liver Fibrotic Indicator Determined. Shi Yong Fang She Xue Za Zhi 18: 312-314.
18. Suou T, Yamada S, Kobayashi J, Hoshino U, Nishimuki E, et al. (1993) Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury. Hepatology 18: 809-815.
19. Kobayashi S, Nakanuma Y, Matsui O, (1994) Histopathology of portal tracts in livers after transcatheter arterial chemo-embolization therapy for hepatocellular carcinoma. J Gastroenterol Hepatol 9: 45-54.
20. Yamashita Y, Torashima M, Oguni T, Yamamoto A, Harada M, et al. (1993) Liver parenchymal changes after transcatheter arterial embolization therapy for hepatoma: CT evaluation. Abdom Imaging 18: 352-356.
21. Wallace S, Kan Z, Li C, (2000) Hepatic chemoembolization: clinical and experimental correlation. Acta Gastroenterol Belg 63: 169-173.
22. Morimoto K, Sakaguchi H, Tanaka T, Yamamoto K, Anai H, et al. (2008) Transarterial chemoembolization using cisplatin powder in a rabbit model of liver cancer. Cardiovasc Intervent Radiol 31: 981-985.
23. Virmani S, Rhee TK, Ryu RK, Sato KT, Lewandowski RJ, et al. (2008) Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors. J Vasc Interv Radiol 19: 1483-1489.
24. Liang B, Zheng CS, Feng GS, Wu HP, Wang Y, et al. (2010) Correlation of Hypoxia-Inducible Factor 1alpha with Angiogenesis in Liver Tumors After Transcatheter Arterial Embolization in an Animal Model. Cardiovasc Intervent Radiol 33: 806-812.